For health care professionals only

The information contained on this site is intended for use only by health care professionals in the United States. Countries outside of the United States may have different regulatory requirements or medical practices than the United States. Therefore, this information may not be appropriate for use outside of the United States.

Are you a health care professional in the United States?

You will now be leaving the NovoSeven® RT website.

You don't have to feel alone living with inhibitors.
Safety

The safety of NovoSeven® RT is proven

Treating a bleed Bleed
In hemophilia, a collection of blood in an area, such as a muscle or joint. safely is important. There are many safety concerns to be aware of. Safety should never be ignored when treating any bleeding disorder.

NovoSeven® RT has many safety features, including:

  • Free of human blood or plasma Plasma
    The fluid part of the blood that contains clotting factors and other proteins.
  • Risk of thrombotic Thrombosis
    An event that takes place when veins or arteries become blocked by platelets that are working to "plug" an injury, preventing blood from flowing normally through the body, and possibly causing a stroke.     adverse events less than 1%
  • NovoSeven® RT does not increase inhibitor Inhibitor
    A substance made by the body that attacks factor so it cannot work as well. For example, a Factor VIII inhibitor would keep Factor VIII from working with other factors and platelets to stop bleeding.     titers Titer
    Concentration or strength of a substance; measures the strength of an inhibitor in a person’s blood.     in hemophilia A or B